Raymond James & Associates Novo Nordisk A S Transaction History

Raymond James & Associates

  • $150 Billion
  • Q2 2024

A detailed history of Raymond James & Associates transactions in Novo Nordisk A S stock. As of the latest transaction made, Raymond James & Associates holds 3,507,198 shares of NVO stock, worth $424 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,507,198
Previous 3,143,731 11.56%
Holding current value
$424 Million
Previous $404 Million 24.02%
% of portfolio
0.33%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
BUY
$122.71 - $146.91 $44.6 Million - $53.4 Million
363,467 Added 11.56%
3,507,198 $501 Million
Q1 2024

Apr 22, 2024
BUY
$102.11 - $135.92 $35.1 Million - $46.8 Million
344,049 Added 12.29%
3,143,731 $404 Million
Q4 2023

Jan 16, 2024
BUY
$87.78 - $105.45 $11.3 Million - $13.6 Million
129,140 Added 4.84%
2,799,682 $290 Million
Q3 2023

Oct 24, 2023
BUY
$90.94 - $199.54 $121 Million - $265 Million
1,327,556 Added 98.85%
2,670,542 $243 Million
Q2 2023

Jul 25, 2023
SELL
$155.98 - $172.65 $17.1 Million - $19 Million
-109,941 Reduced 7.57%
1,342,986 $217 Million
Q1 2023

Apr 14, 2023
BUY
$132.34 - $159.14 $9.31 Million - $11.2 Million
70,370 Added 5.09%
1,452,927 $231 Million
Q4 2022

Feb 08, 2023
BUY
$102.55 - $135.33 $1.21 Million - $1.6 Million
11,832 Added 0.86%
1,382,557 $187 Million
Q3 2022

Oct 25, 2022
SELL
$95.28 - $116.93 $2.12 Million - $2.6 Million
-22,250 Reduced 1.6%
1,370,725 $137 Million
Q2 2022

Aug 12, 2022
BUY
$103.24 - $121.81 $2.48 Million - $2.92 Million
23,986 Added 1.75%
1,392,975 $155 Million
Q1 2022

May 11, 2022
BUY
$93.1 - $112.54 $1.6 Million - $1.93 Million
17,166 Added 1.27%
1,368,989 $152 Million
Q4 2021

Feb 08, 2022
SELL
$95.88 - $117.08 $1.85 Million - $2.26 Million
-19,308 Reduced 1.41%
1,351,823 $151 Million
Q3 2021

Nov 02, 2021
BUY
$84.42 - $106.62 $3.12 Million - $3.95 Million
37,008 Added 2.77%
1,371,131 $132 Million
Q2 2021

Aug 11, 2021
BUY
$67.66 - $84.76 $14.8 Million - $18.5 Million
218,768 Added 19.61%
1,334,123 $112 Million
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $5.02 Million - $5.68 Million
74,861 Added 7.19%
1,115,355 $75.2 Million
Q4 2020

Feb 12, 2021
SELL
$63.89 - $73.8 $5.74 Million - $6.63 Million
-89,840 Reduced 7.95%
1,040,494 $72.7 Million
Q3 2020

Nov 04, 2020
SELL
$63.69 - $70.22 $1.21 Million - $1.34 Million
-19,015 Reduced 1.65%
1,130,334 $78.5 Million
Q2 2020

Jul 28, 2020
SELL
$58.54 - $67.94 $9.75 Million - $11.3 Million
-166,611 Reduced 12.66%
1,149,349 $75.3 Million
Q1 2020

Apr 21, 2020
BUY
$49.46 - $64.78 $5.09 Million - $6.66 Million
102,849 Added 8.48%
1,315,960 $79.2 Million
Q4 2019

Feb 12, 2020
BUY
$49.86 - $58.26 $94,534 - $110,460
1,896 Added 0.16%
1,213,111 $70.2 Million
Q3 2019

Nov 07, 2019
BUY
$47.54 - $53.43 $906,825 - $1.02 Million
19,075 Added 1.6%
1,211,215 $62.6 Million
Q2 2019

Aug 06, 2019
BUY
$46.79 - $52.47 $843,857 - $946,296
18,035 Added 1.54%
1,192,140 $60.8 Million
Q1 2019

May 06, 2019
BUY
$46.36 - $52.63 $24.8 Million - $28.2 Million
535,302 Added 83.8%
1,174,105 $61.4 Million
Q4 2018

Feb 11, 2019
SELL
$41.54 - $47.25 $967,009 - $1.1 Million
-23,279 Reduced 3.52%
638,803 $29.4 Million
Q3 2018

Nov 14, 2018
BUY
$46.76 - $51.24 $576,363 - $631,584
12,326 Added 1.9%
662,082 $31.2 Million
Q2 2018

Aug 14, 2018
BUY
$44.29 - $50.42 $1.42 Million - $1.62 Million
32,152 Added 5.21%
649,756 $30 Million
Q1 2018

May 14, 2018
BUY
$48.49 - $58.14 $2.52 Million - $3.03 Million
52,049 Added 9.2%
617,604 $30.4 Million
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $9.61 Million - $10.9 Million
-202,242 Reduced 26.34%
565,555 $30.4 Million
Q3 2017

Nov 13, 2017
SELL
$41.15 - $49.22 $6.47 Million - $7.74 Million
-157,265 Reduced 17.0%
767,797 $37 Million
Q2 2017

Aug 14, 2017
BUY
N/A
925,062
925,062 $39.7 Million

Others Institutions Holding NVO

# of Institutions
1,991
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email